SHARE
Drug Discovery Market

Drug Discovery Market Forecasts to 2028 - Global Analysis by Technology (Nanotechnology, High Throughput Screening, Combinatorial Chemistry, Pharmacogenomics, Bioanalytical Instruments, Biochips, Bioinformatics and Other Technologies), Service (Medicinal Chemical Services, Biological Services, Drug Metabolism and Pharmacokinetics (DMPK) Services and Other Pharmaceutical Services), Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), Therapeutic Area (Respiratory Disease, Neurology, Infectious and Immune System Diseases, Oncology, Cardiovascular Diseases, Digestive System Diseases, Diabetes and Other Therapeutic Areas) , End Use and By Geography

5.0 (38 reviews)
Published: September 2022 ID: SMRC21872
5.0 (38 reviews)
Published: September 2022 ID: SMRC21872

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Drug Discovery Market is accounted for $47.38 billion in 2022 and is expected to reach $84.86 billion by 2028 growing at a CAGR of 10.2% during the forecast period. In the fields of medicine, biotechnology, and pharmacology, novel candidate medicines are found through the process of drug discovery. In the past, drugs were discovered by accident, as was the case with penicillin, or by identifying the active component in conventional treatments. A technique known as classical pharmacology involved screening chemical libraries of created small molecules, natural products, or extracts in whole cells or organisms to find substances that had desired therapeutic effects.

According to Cardiovascular diseases (CVDs) key facts published by the World Health Organization in June 2021, CVDs are the leading cause of death globally, representing around 32% of all global deaths. According to the American Cancer Society, in 2020, about 1.8 million new cancer cases were expected to be diagnosed and approximately 606,520 cancer deaths may have occurred in the United States. Thus, the increasing burden of a diverse range of diseases among all age groups and its burden, globally, drive the demand for drug discovery and its market.

Market Dynamics:

Driver:

Profound Impact of Oncology on Market Growth

Oncology's use of AI is thought to have tremendous growth potential. Researchers can design new therapies and modify drug use by better understanding how cancer cells develop resistance to anticancer medications with the aid of artificial intelligence (AI). Current research on anticancer drugs can be accelerated by AI technology like machine learning. A prime example of recent developments in the oncology sector is Paige's, a start-up that develops AI diagnostic technology. Through the application of machine learning, the business enables pathologists to accurately diagnose cancer using photographs of tissue samples.

Restrain:

Stringent regulations governing drug discovery and animal usage

During the drug approval process, regulatory agencies' main priorities are safety and efficacy. This aspect can have a considerable impact on the uptake of a certain treatment in emerging markets that are price sensitive. In addition, a number of laws that guarantee the quality of the product (such GMP) frequently raise the cost of manufacturing. The use of animals in the drug discovery process is governed by strict regulations. The most often employed animals in study are mice, rats, fish, amphibians, and reptiles. Governments have introduced rules for animal safety and use in response to ethical questions about this practise, which poses a number of difficulties for drug discovery research. Due to this, businesses are now using alternative methods to reduce the use of animals.

Opportunity:

Advancements in Treatment of Neurological Diseases to Open Profitable Avenues


Numerous prospects for growth may arise from the use of AI to the treatment of neurological conditions. The pharmaceutical sector is working together to investigate new treatments for neurological illnesses. PharmEnable, a drug discovery company located in the UK, and Sosei, a company based in Japan, are working together to find drug leads using Sosei Heprares' CPCR-focused drug design platform and PharmEnable's AI technology. Similar breakthroughs will guarantee significant market growth for AI-based drug discovery.

Threat:

Shortage of Skilled Personnel

The R&D outsourcing market for pharmaceuticals, biotechnology, and medical devices is always changing. Professionals must deliver excellent services, adhere to proper laboratory practises, and stay up with the ongoing developments in pharmaceutical R&D technologies and processes. As they compete for competent and experienced scientists with pharmaceutical and biotechnology corporations, academic institutions, and research organisations, CROs confront difficulties in attracting and keeping highly skilled personnel. Companies must provide higher salaries and other perks in order to compete effectively; this may have an impact on the finances and business performance of competitors, particularly small-scale analytical testing suppliers.

Covid-19 Impact

Drug discovery and development for the treatment of COVID-19 are being performed by screening both novel and existing drugs for their potential to reduce symptoms and stop viral replication. "During COVID-19 pandemic, the need for the development of a drug or vaccine is projected to have a positive impact on the drug discovery services market." In order to better identify drug candidates, future drug discovery technologies including high throughput, bioinformatics, and medicinal chemistry are increasingly being applied in the drug discovery services market. Drug development has significantly benefited from emerging technology, which has made it more sophisticated, accurate, and efficient.

The small molecule segment is expected to be the largest during the forecast period

The small molecule sector dominated the market in terms of drug type. This is a result of the population's rising need for small molecule medications. Because of their small size and weight, small molecule medications are able to treat diseases and easily affect cells. Therefore, the manufacturers' investments in the development of small molecule pharmaceuticals have increased as a result of the increased awareness of the usefulness of small molecule drugs. The small molecule segment is expected to be the largest during the forecast period.

The pharmaceutical corporations segment is expected to have the highest CAGR during the forecast period.

The global market for drug discovery was dominated by pharmaceutical corporations. This is a result of leading pharmaceutical and biotechnology businesses investing more money in the creation of new medicines. The growing elderly population and incidence of chronic diseases are driving up demand for a wide range of cutting-edge medications. The global rise in drug demand has stimulated the market for drug discovery. Additionally, the market expansion has been greatly aided by the biopharmaceutical industry's explosive rise. As a result, pharmaceutical corporations segment is expected to have the highest CAGR during the forecast period.

Region with highest share:

The market for drug discovery globally was dominated by North America with largest share. In terms of global spending on research and development, the US holds the top spot. Furthermore, the majority of the recently developed new pharmaceuticals are protected by US patents. Additionally, the rising frequency of chronic diseases has increased the demand for cutting-edge and novel medications, which has supported the expansion of the drug discovery market in North America. In the US, around half of the population has one or more chronic illnesses. As a result, the nation now spends a lot of money on healthcare. Additionally, the region's growing awareness of biologics is boosting the market's expansion.

Region with highest CAGR:

In the approaching years, it is predicted that Asia Pacific would offer the most opportunities. This can be linked to the region's abundance of CROs. Additionally, some areas are making significant investments in the expansion of the pharmaceutical sector, which is driving up demand for biopharmaceutical goods. In addition, given older individuals are more sensitive to chronic diseases, it is anticipated that the region's growing elderly population would boost drug demand in the near future. Asia Pacific is expected to see the highest CAGR during the projection period.

Key players in the market

Some of the key players profiled in the Drug Discovery Market include Abbott Laboratories Inc., Charles River Laboratories International Inc., Astrazeneca plc, Bayer AG, Merck & Co. Inc., Eli Lilly and Company, Shimadzu Corp, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Pfizer Inc., Novartis AG, Evotec SE, Icon PLC.

Key Developments:

In February 2022, Agilent Technologies Inc bought Virtual Control, an AI and machine learning Software Company, with the goal of obtaining innovative lab testing analytical solutions built by them. Agilent will use the software in its mass spectrometry (GS/MS) and gas chromatography platforms for improving efficiency, productivity, and accuracy.

In January 2020, Bayer collaborated with Exscientia, an artificial intelligence drug discovery company, for the development of cardiovascular and oncology diseases related drug.

In November 2020, Genesis Therapeutics entered AI-driven, multi-target drug discovery partnership with Genentech. The collaboration leverages Genesis’ graph machine learning and drug discovery expertise to identify innovative drug candidates for therapeutic targets in multiple disease areas.

Drug Type Covered:
• Large Molecule
• Small Molecule

Technology Covered:
• Nanotechnology
• High Throughput Screening
• Combinatorial Chemistry
• Pharmacogenomics
• Bioanalytical Instruments
• Biochips
• Bioinformatics
• Other Technologies

Service Covered:
• Medicinal Chemical Services
• Biological Services
• Drug Metabolism and Pharmacokinetics (DMPK) Services
• Other Pharmaceutical Services

Process Covered:
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation

Therapeutic Area Covered:
• Respiratory Disease
• Neurology
• Infectious and Immune System Diseases
• Oncology
• Cardiovascular Diseases
• Digestive System Diseases
• Diabetes
• Other Therapeutic Areas

End User Covered:
• Pharmaceutical Companies
• CROs
• Research Institutes
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
 

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Drug Discovery Market, By Drug Type
5.1 Introduction
5.2 Large Molecule
5.3 Small Molecule

6 Global Drug Discovery Market, By Technology
6.1 Introduction
6.2 Nanotechnology
6.3 High Throughput Screening
6.4 Combinatorial Chemistry
6.5 Pharmacogenomics
6.6 Bioanalytical Instruments
6.7 Biochips
6.8 Bioinformatics
6.9 Other Technologies

7 Global Drug Discovery Market, By Service
7.1 Introduction
7.2 Medicinal Chemical Services
7.3 Biological Services
7.4 Drug Metabolism and Pharmacokinetics (DMPK) Services
7.5 Other Pharmaceutical Services

8 Global Drug Discovery Market, By Process
8.1 Introduction
8.2 Target Selection
8.3 Target Validation
8.4 Hit-To-Lead Identification
8.5 Lead Optimization
8.6 Candidate Validation

9 Global Drug Discovery Market, By Therapeutic Area
9.1 Introduction
9.2 Respiratory Disease
9.3 Neurology
9.4 Infectious and Immune System Diseases
9.5 Oncology
9.6 Cardiovascular Diseases
9.7 Digestive System Diseases
9.8 Diabetes
9.9 Other Therapeutic Areas

10 Global Drug Discovery Market, By End User
10.1 Introduction
10.2 Pharmaceutical Companies
10.3 CROs
10.4 Research Institutes
10.5 Other End Users

11 Global Drug Discovery Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 Abbott Laboratories Inc.
13.2 Charles River Laboratories International Inc.
13.3 Astrazeneca plc
13.4 Bayer AG
13.5 Merck & Co. Inc.
13.6 Eli Lilly and Company
13.7 Shimadzu Corp
13.8 F. Hoffmann-La Roche Ltd
13.9 GlaxoSmithKline PLC
13.10 Agilent Technologies Inc.
13.11 Thermo Fisher Scientific Inc.
13.12 Pfizer Inc.
13.13 Novartis AG
13.14 Evotec SE
13.15 Icon PLC

List of Tables
1 Global Drug Discovery Market Outlook, By Region (2020-2028) ($MN)
2 Global Drug Discovery Market Outlook, By Drug Type(2020-2028) ($MN)
3 Global Drug Discovery Market Outlook, By Large Molecule(2020-2028) ($MN)
4 Global Drug Discovery Market Outlook, By Small Molecule(2020-2028) ($MN)
5 Global Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
6 Global Drug Discovery Market Outlook, By Nanotechnology(2020-2028) ($MN)
7 Global Drug Discovery Market Outlook, By High Throughput Screening(2020-2028) ($MN)
8 Global Drug Discovery Market Outlook, By Combinatorial Chemistry(2020-2028) ($MN)
9 Global Drug Discovery Market Outlook, By Pharmacogenomics(2020-2028) ($MN)
10 Global Drug Discovery Market Outlook, By Bioanalytical Instruments(2020-2028) ($MN)
11 Global Drug Discovery Market Outlook, By Biochips(2020-2028) ($MN)
12 Global Drug Discovery Market Outlook, By Bioinformatics(2020-2028) ($MN)
13 Global Drug Discovery Market Outlook, By Other Technologies(2020-2028) ($MN)
14 Global Drug Discovery Market Outlook, By Service(2020-2028) ($MN)
15 Global Drug Discovery Market Outlook, By Medicinal Chemical Services(2020-2028) ($MN)
16 Global Drug Discovery Market Outlook, By Biological Services(2020-2028) ($MN)
17 Global Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services(2020-2028) ($MN)
18 Global Drug Discovery Market Outlook, By Other Pharmaceutical Services(2020-2028) ($MN)
19 Global Drug Discovery Market Outlook, By Process(2020-2028) ($MN)
20 Global Drug Discovery Market Outlook, By Target Selection(2020-2028) ($MN)
21 Global Drug Discovery Market Outlook, By Target Validation(2020-2028) ($MN)
22 Global Drug Discovery Market Outlook, By Hit-To-Lead Identification(2020-2028) ($MN)
23 Global Drug Discovery Market Outlook, By Lead Optimization(2020-2028) ($MN)
24 Global Drug Discovery Market Outlook, By Candidate Validation(2020-2028) ($MN)
25 Global Drug Discovery Market Outlook, By Therapeutic Area(2020-2028) ($MN)
26 Global Drug Discovery Market Outlook, By Respiratory Disease(2020-2028) ($MN)
27 Global Drug Discovery Market Outlook, By Neurology(2020-2028) ($MN)
28 Global Drug Discovery Market Outlook, By Infectious and Immune System Diseases(2020-2028) ($MN)
29 Global Drug Discovery Market Outlook, By Oncology(2020-2028) ($MN)
30 Global Drug Discovery Market Outlook, By Cardiovascular Diseases(2020-2028) ($MN)
31 Global Drug Discovery Market Outlook, By Digestive System Diseases(2020-2028) ($MN)
32 Global Drug Discovery Market Outlook, By Diabetes(2020-2028) ($MN)
33 Global Drug Discovery Market Outlook, By Other Therapeutic Areas(2020-2028) ($MN)
34 Global Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
35 Global Drug Discovery Market Outlook, By Pharmaceutical Companies(2020-2028) ($MN)
36 Global Drug Discovery Market Outlook, By CROs(2020-2028) ($MN)
37 Global Drug Discovery Market Outlook, By Research Institutes(2020-2028) ($MN)
38 Global Drug Discovery Market Outlook, By Other End Users(2020-2028) ($MN)
39 North America Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
40 North America Drug Discovery Market Outlook, By Drug Type(2020-2028) ($MN)
41 North America Drug Discovery Market Outlook, By Large Molecule(2020-2028) ($MN)
42 North America Drug Discovery Market Outlook, By Small Molecule(2020-2028) ($MN)
43 North America Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
44 North America Drug Discovery Market Outlook, By Nanotechnology(2020-2028) ($MN)
45 North America Drug Discovery Market Outlook, By High Throughput Screening(2020-2028) ($MN)
46 North America Drug Discovery Market Outlook, By Combinatorial Chemistry(2020-2028) ($MN)
47 North America Drug Discovery Market Outlook, By Pharmacogenomics(2020-2028) ($MN)
48 North America Drug Discovery Market Outlook, By Bioanalytical Instruments(2020-2028) ($MN)
49 North America Drug Discovery Market Outlook, By Biochips(2020-2028) ($MN)
50 North America Drug Discovery Market Outlook, By Bioinformatics(2020-2028) ($MN)
51 North America Drug Discovery Market Outlook, By Other Technologies(2020-2028) ($MN)
52 North America Drug Discovery Market Outlook, By Service(2020-2028) ($MN)
53 North America Drug Discovery Market Outlook, By Medicinal Chemical Services(2020-2028) ($MN)
54 North America Drug Discovery Market Outlook, By Biological Services(2020-2028) ($MN)
55 North America Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services(2020-2028) ($MN)
56 North America Drug Discovery Market Outlook, By Other Pharmaceutical Services(2020-2028) ($MN)
57 North America Drug Discovery Market Outlook, By Process(2020-2028) ($MN)
58 North America Drug Discovery Market Outlook, By Target Selection(2020-2028) ($MN)
59 North America Drug Discovery Market Outlook, By Target Validation(2020-2028) ($MN)
60 North America Drug Discovery Market Outlook, By Hit-To-Lead Identification(2020-2028) ($MN)
61 North America Drug Discovery Market Outlook, By Lead Optimization(2020-2028) ($MN)
62 North America Drug Discovery Market Outlook, By Candidate Validation(2020-2028) ($MN)
63 North America Drug Discovery Market Outlook, By Therapeutic Area(2020-2028) ($MN)
64 North America Drug Discovery Market Outlook, By Respiratory Disease(2020-2028) ($MN)
65 North America Drug Discovery Market Outlook, By Neurology(2020-2028) ($MN)
66 North America Drug Discovery Market Outlook, By Infectious and Immune System Diseases(2020-2028) ($MN)
67 North America Drug Discovery Market Outlook, By Oncology(2020-2028) ($MN)
68 North America Drug Discovery Market Outlook, By Cardiovascular Diseases(2020-2028) ($MN)
69 North America Drug Discovery Market Outlook, By Digestive System Diseases(2020-2028) ($MN)
70 North America Drug Discovery Market Outlook, By Diabetes(2020-2028) ($MN)
71 North America Drug Discovery Market Outlook, By Other Therapeutic Areas(2020-2028) ($MN)
72 North America Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
73 North America Drug Discovery Market Outlook, By Pharmaceutical Companies(2020-2028) ($MN)
74 North America Drug Discovery Market Outlook, By CROs(2020-2028) ($MN)
75 North America Drug Discovery Market Outlook, By Research Institutes(2020-2028) ($MN)
76 North America Drug Discovery Market Outlook, By Other End Users(2020-2028) ($MN)
77 Europe Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
78 Europe Drug Discovery Market Outlook, By Drug Type(2020-2028) ($MN)
79 Europe Drug Discovery Market Outlook, By Large Molecule(2020-2028) ($MN)
80 Europe Drug Discovery Market Outlook, By Small Molecule(2020-2028) ($MN)
81 Europe Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
82 Europe Drug Discovery Market Outlook, By Nanotechnology(2020-2028) ($MN)
83 Europe Drug Discovery Market Outlook, By High Throughput Screening(2020-2028) ($MN)
84 Europe Drug Discovery Market Outlook, By Combinatorial Chemistry(2020-2028) ($MN)
85 Europe Drug Discovery Market Outlook, By Pharmacogenomics(2020-2028) ($MN)
86 Europe Drug Discovery Market Outlook, By Bioanalytical Instruments(2020-2028) ($MN)
87 Europe Drug Discovery Market Outlook, By Biochips(2020-2028) ($MN)
88 Europe Drug Discovery Market Outlook, By Bioinformatics(2020-2028) ($MN)
89 Europe Drug Discovery Market Outlook, By Other Technologies(2020-2028) ($MN)
90 Europe Drug Discovery Market Outlook, By Service(2020-2028) ($MN)
91 Europe Drug Discovery Market Outlook, By Medicinal Chemical Services(2020-2028) ($MN)
92 Europe Drug Discovery Market Outlook, By Biological Services(2020-2028) ($MN)
93 Europe Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services(2020-2028) ($MN)
94 Europe Drug Discovery Market Outlook, By Other Pharmaceutical Services(2020-2028) ($MN)
95 Europe Drug Discovery Market Outlook, By Process(2020-2028) ($MN)
96 Europe Drug Discovery Market Outlook, By Target Selection(2020-2028) ($MN)
97 Europe Drug Discovery Market Outlook, By Target Validation(2020-2028) ($MN)
98 Europe Drug Discovery Market Outlook, By Hit-To-Lead Identification(2020-2028) ($MN)
99 Europe Drug Discovery Market Outlook, By Lead Optimization(2020-2028) ($MN)
100 Europe Drug Discovery Market Outlook, By Candidate Validation(2020-2028) ($MN)
101 Europe Drug Discovery Market Outlook, By Therapeutic Area(2020-2028) ($MN)
102 Europe Drug Discovery Market Outlook, By Respiratory Disease(2020-2028) ($MN)
103 Europe Drug Discovery Market Outlook, By Neurology(2020-2028) ($MN)
104 Europe Drug Discovery Market Outlook, By Infectious and Immune System Diseases(2020-2028) ($MN)
105 Europe Drug Discovery Market Outlook, By Oncology(2020-2028) ($MN)
106 Europe Drug Discovery Market Outlook, By Cardiovascular Diseases(2020-2028) ($MN)
107 Europe Drug Discovery Market Outlook, By Digestive System Diseases(2020-2028) ($MN)
108 Europe Drug Discovery Market Outlook, By Diabetes(2020-2028) ($MN)
109 Europe Drug Discovery Market Outlook, By Other Therapeutic Areas(2020-2028) ($MN)
110 Europe Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
111 Europe Drug Discovery Market Outlook, By Pharmaceutical Companies(2020-2028) ($MN)
112 Europe Drug Discovery Market Outlook, By CROs(2020-2028) ($MN)
113 Europe Drug Discovery Market Outlook, By Research Institutes(2020-2028) ($MN)
114 Europe Drug Discovery Market Outlook, By Other End Users(2020-2028) ($MN)
115 Asia Pacific Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
116 Asia Pacific Drug Discovery Market Outlook, By Drug Type(2020-2028) ($MN)
117 Asia Pacific Drug Discovery Market Outlook, By Large Molecule(2020-2028) ($MN)
118 Asia Pacific Drug Discovery Market Outlook, By Small Molecule(2020-2028) ($MN)
119 Asia Pacific Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
120 Asia Pacific Drug Discovery Market Outlook, By Nanotechnology(2020-2028) ($MN)
121 Asia Pacific Drug Discovery Market Outlook, By High Throughput Screening(2020-2028) ($MN)
122 Asia Pacific Drug Discovery Market Outlook, By Combinatorial Chemistry(2020-2028) ($MN)
123 Asia Pacific Drug Discovery Market Outlook, By Pharmacogenomics(2020-2028) ($MN)
124 Asia Pacific Drug Discovery Market Outlook, By Bioanalytical Instruments(2020-2028) ($MN)
125 Asia Pacific Drug Discovery Market Outlook, By Biochips(2020-2028) ($MN)
126 Asia Pacific Drug Discovery Market Outlook, By Bioinformatics(2020-2028) ($MN)
127 Asia Pacific Drug Discovery Market Outlook, By Other Technologies(2020-2028) ($MN)
128 Asia Pacific Drug Discovery Market Outlook, By Service(2020-2028) ($MN)
129 Asia Pacific Drug Discovery Market Outlook, By Medicinal Chemical Services(2020-2028) ($MN)
130 Asia Pacific Drug Discovery Market Outlook, By Biological Services(2020-2028) ($MN)
131 Asia Pacific Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services(2020-2028) ($MN)
132 Asia Pacific Drug Discovery Market Outlook, By Other Pharmaceutical Services(2020-2028) ($MN)
133 Asia Pacific Drug Discovery Market Outlook, By Process(2020-2028) ($MN)
134 Asia Pacific Drug Discovery Market Outlook, By Target Selection(2020-2028) ($MN)
135 Asia Pacific Drug Discovery Market Outlook, By Target Validation(2020-2028) ($MN)
136 Asia Pacific Drug Discovery Market Outlook, By Hit-To-Lead Identification(2020-2028) ($MN)
137 Asia Pacific Drug Discovery Market Outlook, By Lead Optimization(2020-2028) ($MN)
138 Asia Pacific Drug Discovery Market Outlook, By Candidate Validation(2020-2028) ($MN)
139 Asia Pacific Drug Discovery Market Outlook, By Therapeutic Area(2020-2028) ($MN)
140 Asia Pacific Drug Discovery Market Outlook, By Respiratory Disease(2020-2028) ($MN)
141 Asia Pacific Drug Discovery Market Outlook, By Neurology(2020-2028) ($MN)
142 Asia Pacific Drug Discovery Market Outlook, By Infectious and Immune System Diseases(2020-2028) ($MN)
143 Asia Pacific Drug Discovery Market Outlook, By Oncology(2020-2028) ($MN)
144 Asia Pacific Drug Discovery Market Outlook, By Cardiovascular Diseases(2020-2028) ($MN)
145 Asia Pacific Drug Discovery Market Outlook, By Digestive System Diseases(2020-2028) ($MN)
146 Asia Pacific Drug Discovery Market Outlook, By Diabetes(2020-2028) ($MN)
147 Asia Pacific Drug Discovery Market Outlook, By Other Therapeutic Areas(2020-2028) ($MN)
148 Asia Pacific Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
149 Asia Pacific Drug Discovery Market Outlook, By Pharmaceutical Companies(2020-2028) ($MN)
150 Asia Pacific Drug Discovery Market Outlook, By CROs(2020-2028) ($MN)
151 Asia Pacific Drug Discovery Market Outlook, By Research Institutes(2020-2028) ($MN)
152 Asia Pacific Drug Discovery Market Outlook, By Other End Users(2020-2028) ($MN)
153 South America Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
154 South America Drug Discovery Market Outlook, By Drug Type(2020-2028) ($MN)
155 South America Drug Discovery Market Outlook, By Large Molecule(2020-2028) ($MN)
156 South America Drug Discovery Market Outlook, By Small Molecule(2020-2028) ($MN)
157 South America Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
158 South America Drug Discovery Market Outlook, By Nanotechnology(2020-2028) ($MN)
159 South America Drug Discovery Market Outlook, By High Throughput Screening(2020-2028) ($MN)
160 South America Drug Discovery Market Outlook, By Combinatorial Chemistry(2020-2028) ($MN)
161 South America Drug Discovery Market Outlook, By Pharmacogenomics(2020-2028) ($MN)
162 South America Drug Discovery Market Outlook, By Bioanalytical Instruments(2020-2028) ($MN)
163 South America Drug Discovery Market Outlook, By Biochips(2020-2028) ($MN)
164 South America Drug Discovery Market Outlook, By Bioinformatics(2020-2028) ($MN)
165 South America Drug Discovery Market Outlook, By Other Technologies(2020-2028) ($MN)
166 South America Drug Discovery Market Outlook, By Service(2020-2028) ($MN)
167 South America Drug Discovery Market Outlook, By Medicinal Chemical Services(2020-2028) ($MN)
168 South America Drug Discovery Market Outlook, By Biological Services(2020-2028) ($MN)
169 South America Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services(2020-2028) ($MN)
170 South America Drug Discovery Market Outlook, By Other Pharmaceutical Services(2020-2028) ($MN)
171 South America Drug Discovery Market Outlook, By Process(2020-2028) ($MN)
172 South America Drug Discovery Market Outlook, By Target Selection(2020-2028) ($MN)
173 South America Drug Discovery Market Outlook, By Target Validation(2020-2028) ($MN)
174 South America Drug Discovery Market Outlook, By Hit-To-Lead Identification(2020-2028) ($MN)
175 South America Drug Discovery Market Outlook, By Lead Optimization(2020-2028) ($MN)
176 South America Drug Discovery Market Outlook, By Candidate Validation(2020-2028) ($MN)
177 South America Drug Discovery Market Outlook, By Therapeutic Area(2020-2028) ($MN)
178 South America Drug Discovery Market Outlook, By Respiratory Disease(2020-2028) ($MN)
179 South America Drug Discovery Market Outlook, By Neurology(2020-2028) ($MN)
180 South America Drug Discovery Market Outlook, By Infectious and Immune System Diseases(2020-2028) ($MN)
181 South America Drug Discovery Market Outlook, By Oncology(2020-2028) ($MN)
182 South America Drug Discovery Market Outlook, By Cardiovascular Diseases(2020-2028) ($MN)
183 South America Drug Discovery Market Outlook, By Digestive System Diseases(2020-2028) ($MN)
184 South America Drug Discovery Market Outlook, By Diabetes(2020-2028) ($MN)
185 South America Drug Discovery Market Outlook, By Other Therapeutic Areas(2020-2028) ($MN)
186 South America Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
187 South America Drug Discovery Market Outlook, By Pharmaceutical Companies(2020-2028) ($MN)
188 South America Drug Discovery Market Outlook, By CROs(2020-2028) ($MN)
189 South America Drug Discovery Market Outlook, By Research Institutes(2020-2028) ($MN)
190 South America Drug Discovery Market Outlook, By Other End Users(2020-2028) ($MN)
191 Middle East & Africa Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
192 Middle East & Africa Drug Discovery Market Outlook, By Drug Type(2020-2028) ($MN)
193 Middle East & Africa Drug Discovery Market Outlook, By Large Molecule(2020-2028) ($MN)
194 Middle East & Africa Drug Discovery Market Outlook, By Small Molecule(2020-2028) ($MN)
195 Middle East & Africa Drug Discovery Market Outlook, By Technology (2020-2028) ($MN)
196 Middle East & Africa Drug Discovery Market Outlook, By Nanotechnology(2020-2028) ($MN)
197 Middle East & Africa Drug Discovery Market Outlook, By High Throughput Screening(2020-2028) ($MN)
198 Middle East & Africa Drug Discovery Market Outlook, By Combinatorial Chemistry(2020-2028) ($MN)
199 Middle East & Africa Drug Discovery Market Outlook, By Pharmacogenomics(2020-2028) ($MN)
200 Middle East & Africa Drug Discovery Market Outlook, By Bioanalytical Instruments(2020-2028) ($MN)
201 Middle East & Africa Drug Discovery Market Outlook, By Biochips(2020-2028) ($MN)
202 Middle East & Africa Drug Discovery Market Outlook, By Bioinformatics(2020-2028) ($MN)
203 Middle East & Africa Drug Discovery Market Outlook, By Other Technologies(2020-2028) ($MN)
204 Middle East & Africa Drug Discovery Market Outlook, By Service(2020-2028) ($MN)
205 Middle East & Africa Drug Discovery Market Outlook, By Medicinal Chemical Services(2020-2028) ($MN)
206 Middle East & Africa Drug Discovery Market Outlook, By Biological Services(2020-2028) ($MN)
207 Middle East & Africa Drug Discovery Market Outlook, By Drug Metabolism and Pharmacokinetics (DMPK) Services(2020-2028) ($MN)
208 Middle East & Africa Drug Discovery Market Outlook, By Other Pharmaceutical Services(2020-2028) ($MN)
209 Middle East & Africa Drug Discovery Market Outlook, By Process(2020-2028) ($MN)
210 Middle East & Africa Drug Discovery Market Outlook, By Target Selection(2020-2028) ($MN)
211 Middle East & Africa Drug Discovery Market Outlook, By Target Validation(2020-2028) ($MN)
212 Middle East & Africa Drug Discovery Market Outlook, By Hit-To-Lead Identification(2020-2028) ($MN)
213 Middle East & Africa Drug Discovery Market Outlook, By Lead Optimization(2020-2028) ($MN)
214 Middle East & Africa Drug Discovery Market Outlook, By Candidate Validation(2020-2028) ($MN)
215 Middle East & Africa Drug Discovery Market Outlook, By Therapeutic Area(2020-2028) ($MN)
216 Middle East & Africa Drug Discovery Market Outlook, By Respiratory Disease(2020-2028) ($MN)
217 Middle East & Africa Drug Discovery Market Outlook, By Neurology(2020-2028) ($MN)
218 Middle East & Africa Drug Discovery Market Outlook, By Infectious and Immune System Diseases(2020-2028) ($MN)
219 Middle East & Africa Drug Discovery Market Outlook, By Oncology(2020-2028) ($MN)
220 Middle East & Africa Drug Discovery Market Outlook, By Cardiovascular Diseases(2020-2028) ($MN)
221 Middle East & Africa Drug Discovery Market Outlook, By Digestive System Diseases(2020-2028) ($MN)
222 Middle East & Africa Drug Discovery Market Outlook, By Diabetes(2020-2028) ($MN)
223 Middle East & Africa Drug Discovery Market Outlook, By Other Therapeutic Areas(2020-2028) ($MN)
224 Middle East & Africa Drug Discovery Market Outlook, By End User (2020-2028) ($MN)
225 Middle East & Africa Drug Discovery Market Outlook, By Pharmaceutical Companies(2020-2028) ($MN)
226 Middle East & Africa Drug Discovery Market Outlook, By CROs(2020-2028) ($MN)
227 Middle East & Africa Drug Discovery Market Outlook, By Research Institutes(2020-2028) ($MN)
228 Middle East & Africa Drug Discovery Market Outlook, By Other End Users(2020-2028) ($MN)
 

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials